Modalis Therapeutics Corporation (TYO:4883)

Modalis Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2,812	3,575	1,883	2,933	4,936
Cash & Short-Term Investments	2,812	3,575	1,883	2,933	4,936
Cash Growth	-21.34%	89.86%	-35.80%	-40.58%	-8.95%
Inventory	-	-	6	40	-
Other Current Assets	80	42	67	88	131
Total Current Assets	2,892	3,617	1,956	3,061	5,067
Property, Plant & Equipment	-	-	-	-	223
Long-Term Investments	71	74	69	68	73
Other Intangible Assets	-	-	-	-	705
Other Long-Term Assets	1	-	-	-	1
Total Assets	2,964	3,691	2,025	3,129	6,069
Accounts Payable	1	1	-	-	1
Accrued Expenses	25	20	91	17	25
Current Income Taxes Payable	107	95	105	123	126
Other Current Liabilities	1	1	2	1	28
Total Current Liabilities	134	117	198	141	180
Long-Term Debt	-	-	412	-	-
Long-Term Deferred Tax Liabilities	-	-	-	-	5
Other Long-Term Liabilities	38	28	36	49	335
Total Liabilities	172	145	646	190	520
Common Stock	1,728	1,758	1,217	2,094	2,744
Additional Paid-In Capital	3,049	3,080	2,539	3,416	4,066
Retained Earnings	-2,037	-1,325	-2,410	-2,605	-1,266
Comprehensive Income & Other	52	33	33	34	5
Shareholders' Equity	2,792	3,546	1,379	2,939	5,549
Total Liabilities & Equity	2,964	3,691	2,025	3,129	6,069
Total Debt	-	-	412	-	-
Net Cash (Debt)	2,812	3,575	1,471	2,933	4,936
Net Cash Growth	-21.34%	143.03%	-49.85%	-40.58%	-8.95%
Net Cash Per Share	36.39	77.50	47.50	100.77	171.67
Filing Date Shares Outstanding	83.05	73.55	33.81	30.09	29.04
Total Common Shares Outstanding	83.05	69.4	33.36	29.36	28.97
Working Capital	2,758	3,500	1,758	2,920	4,887
Book Value Per Share	33.62	51.09	41.34	100.09	191.56
Tangible Book Value	2,792	3,546	1,379	2,939	4,844
Tangible Book Value Per Share	33.62	51.09	41.34	100.09	167.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.